These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6681739)

  • 1. Diurnal variation in prednisolone kinetics.
    English J; Dunne M; Marks V
    Clin Pharmacol Ther; 1983 Mar; 33(3):381-5. PubMed ID: 6681739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in prednisolone disposition as a result of time of administration, gender and dose.
    Meffin PJ; Brooks PM; Sallustio BC
    Br J Clin Pharmacol; 1984 Apr; 17(4):395-404. PubMed ID: 6721985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisolone concentrations in plasma, saliva and urine.
    Chakraborty J; Hayes M; English J; Baylis M; Marks V
    Eur J Clin Pharmacol; 1981 Jan; 19(1):79-81. PubMed ID: 7461028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin reduces effectiveness and bioavailability of prednisolone.
    McAllister WA; Thompson PJ; Al-Habet SM; Rogers HJ
    Br Med J (Clin Res Ed); 1983 Mar; 286(6369):923-5. PubMed ID: 6403136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives.
    Legler UF; Benet LZ
    Clin Pharmacol Ther; 1986 Apr; 39(4):425-9. PubMed ID: 3956058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays.
    Meikle AW; Weed JA; Tyler FH
    J Clin Endocrinol Metab; 1975 Oct; 41(4):717-21. PubMed ID: 1176582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inflammatory bowel disease on absorption and disposition of prednisolone.
    Milsap RL; George DE; Szefler SJ; Murray KA; Lebenthal E; Jusko WJ
    Dig Dis Sci; 1983 Feb; 28(2):161-8. PubMed ID: 6825536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of prednisolone during phenytoin therapy.
    Petereit LB; Meikle AW
    Clin Pharmacol Ther; 1977 Dec; 22(6):912-6. PubMed ID: 923186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisolone clearance: a possible determinant for glucocorticoid efficacy in patients with oral vesiculo-erosive diseases.
    Lozada F; Frey FJ; Benet LZ
    J Dent Res; 1983 May; 62(5):575-7. PubMed ID: 6573375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.
    Unadkat JD; Rowland M
    Drug Metab Dispos; 1985; 13(4):503-9. PubMed ID: 2863117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal variation of prednisolone binding to serum corticosteroid-binding globulin in man.
    Angeli A; Frajria R; De Paoli R; Fonzo D; Ceresa F
    Clin Pharmacol Ther; 1978 Jan; 23(1):47-53. PubMed ID: 563315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in prednisolone disposition as a result of oral contraceptive use and dose.
    Meffin PJ; Wing LM; Sallustio BC; Brooks PM
    Br J Clin Pharmacol; 1984 Jun; 17(6):655-64. PubMed ID: 6743464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cimetidine and ranitidine on the conversion of prednisone to prednisolone.
    Sirgo MA; Rocci ML; Ferguson RK; Eshelman FN; Vlasses PH
    Clin Pharmacol Ther; 1985 May; 37(5):534-8. PubMed ID: 3987177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of prednisolone in normal and asthmatic subjects in relation to dose.
    McAllister WA; Winfield CR; Collins JV
    Eur J Clin Pharmacol; 1981; 20(2):141-5. PubMed ID: 7262175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid effects on the diurnal rhythm of circulating leptin levels.
    Nishiyama M; Makino S; Suemaru S; Nanamiya W; Asaba K; Kaneda T; Mimoto T; Nishioka T; Takao T; Hashimoto K
    Horm Res; 2000; 54(2):69-73. PubMed ID: 11251369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive treatment policies. A) Glucocorticoids: absorption of prednisolone. I. The effect of fasting, food, and food combined with antacids.
    Bergrem H; Djøseland O; Jervell J; Rugstad HE
    Scand J Urol Nephrol Suppl; 1981; 64():167-73. PubMed ID: 6959258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme. Investigation of diurnal variation, the effect of a large dose of prednisolone, and prednisolone pharmacokinetics in patients with sarcoidosis.
    Thompson PJ; Kemp MW; McAllister WA; Al Habet SM; Turner-Warwick ME
    Am Rev Respir Dis; 1986 Nov; 134(5):1075-7. PubMed ID: 3022627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered prednisolone kinetics in patients with the nephrotic syndrome.
    Frey FJ; Frey BM
    Nephron; 1982; 32(1):45-8. PubMed ID: 7177276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisolone pharmacokinetics and protein-binding in patients with portosystemic shunt.
    Bergrem H; Ritland S; Opedal I; Bergan A
    Scand J Gastroenterol; 1983 Mar; 18(2):273-6. PubMed ID: 6673058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in prednisolone pharmacokinetics and protein binding during treatment with rifampicin.
    Bergrem H; Refvem OK
    Proc Eur Dial Transplant Assoc; 1983; 19():552-7. PubMed ID: 6878255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.